BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8856756)

  • 1. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
    Paterson DL; Rice LB
    Clin Infect Dis; 2003 Apr; 36(8):1006-12. PubMed ID: 12684913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The participation of pharmacist in antibiotic related activities of Hungarian hospitals and intensive care units].
    Benko R; Matuz M; Hajdú E; Peto Z; Hegedus A; Bogár L; Soós G
    Acta Pharm Hung; 2009; 79(2):57-62. PubMed ID: 19634635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic Use at German University Hospitals (Project INTERUNI-II). Results for Medical Intensive Care, Hematology-Oncology, and Other Medical Service Areas].
    de With K; Bergner J; Bühner R; Dörje F; Gonnermann C; Haber M; Hartmann M; Rothe U; Strehl E; Steib-Bauert M; Kern WV
    Med Klin (Munich); 2004 Jul; 99(7):347-54. PubMed ID: 15322713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.
    Erlandsson M; Burman LG; Cars O; Gill H; Nilsson LE; Walther SM; Hanberger H;
    Scand J Infect Dis; 2007; 39(1):63-9. PubMed ID: 17366015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diversity of antibiotic use on the development of antimicrobial resistance.
    Sandiumenge A; Diaz E; Rodriguez A; Vidaur L; Canadell L; Olona M; Rue M; Rello J
    J Antimicrob Chemother; 2006 Jun; 57(6):1197-204. PubMed ID: 16565158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical choices of antibiotics: judging judicious use.
    Steinberg I
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1178-88. PubMed ID: 11187441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?
    Balabanova Y; Fedorin I; Kuznetsov S; Graham C; Ruddy M; Atun R; Coker R; Drobniewski F
    J Antimicrob Chemother; 2004 Sep; 54(3):673-9. PubMed ID: 15317742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
    Sintchenko V; Iredell JR; Gilbert GL; Coiera E
    J Am Med Inform Assoc; 2005; 12(4):398-402. PubMed ID: 15802478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial stewardship.
    Fishman N
    Am J Med; 2006 Jun; 119(6 Suppl 1):S53-61; discussion S62-70. PubMed ID: 16735152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.